Ligand Pharmaceuticals

Yahoo Finance • 3 days ago

Ligand to Participate in June Investor Conferences

Ligand Pharmaceuticals JUPITER, Fla., May 27, 2026 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that its senior management team will participate in the following upcoming investor conferences: St... Full story

Yahoo Finance • 11 days ago

Is Genpact Stock a Buy After Hedge Fund Rice Hall James Raised Its Stake by $14 Million?

What happened According to a Securities and Exchange Commission (SEC) filing dated May 15, 2026, Rice Hall James & Associates, LLC increased its holding in Genpact(NYSE:G) by 445,743 shares during the first quarter. The estimated transac... Full story

Yahoo Finance • 14 days ago

Is WaterBridge Stock a Buy After Ranger Investment Raised Its Stake by 345,000 Shares?

What happened According to a Securities and Exchange Commission (SEC) filing dated May 15, 2026, Ranger Investment Management, L.P. increased its holding in WaterBridge Infrastructure LLC(NYSE:WBI) by 345,554 shares during the first quart... Full story

Yahoo Finance • 25 days ago

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: XOMA Royalty Corporation (Nasdaq – XOMA), Organon & Co. (NYSE – OGN), RE/MAX Holdings, Inc. (NYSE – RMAX), Soleno Therapeutics, Inc. (Nasdaq – SLNO)

BALA CYNWYD, Pa., May 05, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Acke... Full story

Yahoo Finance • 28 days ago

Villere St Denis Dumps 134,000 Tidewater (TDW) Shares Worth $9.3 Million

What happened According to a recent SEC filing dated April 30, 2026, Villere St Denis J & Co LLC reduced its exposure to Tidewater(NYSE:TDW) by 134,355 shares. The estimated transaction value, calculated using the quarter’s average closin... Full story

Yahoo Finance • last month

Royalty Powerhouse: Ligand And Xoma Unite In $739 Million Deal

Ligand Pharmaceuticals snatched up Xoma Royalty in a deal worth $739 million, the companies said Monday as both biotech stocks jumped. Continue Reading... Full story

Yahoo Finance • last month

Ligand Pharmaceuticals buying Xoma Royalty for $739 million

Ligand Pharmaceuticals agreed to acquire Xoma Royalty Corporation for $39 per share in an all-cash deal valued at about $739 million, the two companies announced April 27. The royalty aggregator model, which both companies use, involves t... Full story

Yahoo Finance • 2 months ago

CLO Sells LGND 5,000 Shares for $1.0 Million

Key Points 5,000 shares were sold on March 4, 2026, through an option exercise and immediate disposition, yielding a transaction value of ~$1.03 million at around $206.35 per share. The sale represented 11.94% of Reardon's direct holdings... Full story

Yahoo Finance • 2 months ago

Ligand Advances Strategic Growth with Expanded and Strengthened Business Development Team

JUPITER, Fla., March 26, 2026 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced it has appointed two leading healthcare investors, Peter Renehan, MD, and Lee Brown as Vice Presidents of Investments an... Full story

Yahoo Finance • 2 months ago

Two Biotech Stocks Hover Near Highs; Natural Gas And Finance Names Show Resilience

Two biotech stocks, Ligand Pharmaceuticals and United Therapeutics, are showing resilient action in Friday's stock market. Continue Reading... Full story

Yahoo Finance • 3 months ago

Assessing Ligand Pharmaceuticals (LGND) Valuation After Bank Of America’s New Buy Rating

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Why Ligand Pharmaceuticals is in Focus Right Now Ligand Pharmaceuticals (LGND) is back on investor radars after Bank... Full story

Yahoo Finance • 3 months ago

Oracle, Nike upgraded: Wall Street's top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: JPMorgan upgraded Oracle (ORCL) to Over... Full story

Yahoo Finance • 3 months ago

Ligand gains new Buy from BofA on high-margin, less risky narrative

[Wall Street New York stock exchange stock market] alexsl Ligand Pharmaceuticals (LGND [https://seekingalpha.com/symbol/LGND]) traded higher in the premarket on Wednesday after Bank of America launched its coverage with a Buy recommendati... Full story

Yahoo Finance • 3 months ago

Here Are Wednesday’s Top Wall Street Analyst Research Calls: CrowdStrike, Harley-Davidson, Intuitive Surgical, Medline, Nike, Oracle, Planet Fitness, Vici Properties, and More

Quick Read After a strong Monday, the stock market took a breather yesterday as investors continued to reset in anticipation of a changing investment landscape. The potential for a quick conclusion to the Iran war is keeping the selling p... Full story

Yahoo Finance • 3 months ago

Ligand Pharma (LGND) Earnings Call Transcript

Image source: The Motley Fool. DATE Thursday, February 26, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Chief Executive Officer — Todd DavisChief Financial Officer — Octavio EspinozaVice President, Portfolio Strategy and Investments — Lauren... Full story

Yahoo Finance • 3 months ago

Ligand: Q4 Earnings Snapshot

JUPITER, Fla. (AP) — JUPITER, Fla. (AP) — Ligand Pharmaceuticals Inc. (LGND) on Thursday reported fourth-quarter earnings of $44.8 million. On a per-share basis, the Jupiter, Florida-based company said it had net income of $2.12. Earnings... Full story

Yahoo Finance • 3 months ago

This $38.8 Million Vicor Bet Is Getting Bigger Amid a 200% Stock Surge

On February 13, 2026, Ashford Capital Management disclosed a buy of 128,664 shares of Vicor(NASDAQ:VICR), with an estimated transaction value of $10.94 million based on quarterly average pricing. What happened According to a filing with... Full story

Yahoo Finance • 3 months ago

What Investors Should Know as One Fund Sells $11 Million of Cavco Industries Stock

On February 13, 2026, Ashford Capital Management disclosed in a Securities and Exchange Commission filing that it reduced its position in Cavco Industries(NASDAQ:CVCO) by 19,607 shares, an estimated $11.11 million trade based on quarterly... Full story

Yahoo Finance • 3 months ago

Fund Sells $23 Million in Globalstar as Stock Surges 170% in One Year

On February 13, 2026, Ashford Capital Management reported selling 410,326 shares of Globalstar(NASDAQ:GSAT), with the estimated transaction value at $22.66 million based on quarterly average pricing. What happened According to an SEC fil... Full story

Yahoo Finance • 3 months ago

Chime Is Down 27% From Its IPO Price, Yet Posting 29% Revenue Growth: Why This New $15 Million Bet Stands Out

On February 13, 2026, Ranger Investment Management disclosed a new position in Chime Financial(NASDAQ:CHYM), acquiring 591,255 shares in a trade estimated at $14.88 million. What happened According to the SEC filing dated February 13, 20... Full story